Neumann Capital Management LLC Sells 3,980 Shares of CVS Health Co. (NYSE:CVS)

Neumann Capital Management LLC reduced its stake in CVS Health Co. (NYSE:CVS) by 9.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,951 shares of the pharmacy operator’s stock after selling 3,980 shares during the period. Neumann Capital Management LLC’s holdings in CVS Health were worth $1,659,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Ariel Investments LLC boosted its stake in CVS Health by 10.3% in the second quarter. Ariel Investments LLC now owns 669,084 shares of the pharmacy operator’s stock valued at $39,516,000 after buying an additional 62,475 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of CVS Health by 33.5% in the 2nd quarter. AQR Capital Management LLC now owns 5,289,788 shares of the pharmacy operator’s stock valued at $310,722,000 after purchasing an additional 1,327,855 shares in the last quarter. APG Asset Management N.V. grew its holdings in shares of CVS Health by 0.9% during the 2nd quarter. APG Asset Management N.V. now owns 1,108,877 shares of the pharmacy operator’s stock valued at $61,106,000 after purchasing an additional 10,096 shares during the last quarter. Employees Retirement System of Texas lifted its stake in CVS Health by 12.9% in the 2nd quarter. Employees Retirement System of Texas now owns 104,590 shares of the pharmacy operator’s stock valued at $6,177,000 after purchasing an additional 11,950 shares during the last quarter. Finally, Drucker Wealth 3.0 LLC acquired a new stake in CVS Health in the second quarter valued at approximately $502,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on CVS. Piper Sandler dropped their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Evercore ISI upped their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Truist Financial decreased their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Stock Performance

NYSE:CVS opened at $53.87 on Friday. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The business has a fifty day simple moving average of $51.23 and a two-hundred day simple moving average of $56.24. The company has a market capitalization of $67.79 billion, a P/E ratio of 13.67, a P/E/G ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter last year, the company earned $2.21 EPS. The firm’s revenue was up 6.3% compared to the same quarter last year. On average, analysts expect that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.94%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.